Kidney failure, death seen with Novartis' Exjade-FDA

(Reuters) - The agency added that Novartis has already included the new
concerns on the drug's label. The company has also notified
doctors, who the FDA said should take steps to monitor at-risk
patients.




Read more at Reuters.com Government Filings News